Argenx
ARGX
#452
Rank
HK$409.74 B
Marketcap
HK$6,579
Share price
-0.40%
Change (1 day)
34.05%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): HK$68.96

According to Argenx 's latest financial reports the company's current EPS (TTM) is HK$68.94. In 2024 the company made an earnings per share (EPS) of HK$108.18 an increase over its 2023 EPS that were of -HK$40.10.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$68.96-36.26%
2024HK$108.18-369.77%
2023-HK$40.10-60.46%
2022-HK$101.4263.33%
2021-HK$62.10-40.37%
2020-HK$104.14183.47%
2019-HK$36.74123.09%
2018-HK$16.4754.93%
2017-HK$10.6314.07%
2016-HK$9.3213.05%
2015-HK$8.24-36.34%
2014-HK$12.95209.04%
2013-HK$4.19-33.99%
2012-HK$6.35185.59%
2011-HK$2.22